Bronstein, Gewirtz & Grossman, LLC Is Investigating Bausch + Lomb (BLCO) And Encourages Investors to Connect
NEW YORK CITY, NY / ACCESS Newswire / April 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
Bronstein, Gewirtz & Grossman, LLC Encourages Bausch + Lomb (BLCO) Stockholders to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
StockStory.org on MSN10d
Why Bausch + Lomb (BLCO) Stock Is Nosediving
Shares of eyecare company Bausch + Lomb (NYSE:BLCO) fell 10.6% in the afternoon session after the company announced the ...
Stifel Nicolaus Issues Pessimistic Forecast for Bausch + Lomb (NYSE:BLCO) Stock Price
Bausch + Lomb (NYSE:BLCO – Get Free Report) had its price objective lowered by stock analysts at Stifel Nicolaus from $17.00 ...
Fintel on MSN9d
Wells Fargo Downgrades Bausch + Lomb (BLCO)
Fintel reports that on March 28, 2025, Wells Fargo downgraded their outlook for Bausch + Lomb (NYSE:BLCO) from Overweight to ...
Bausch + Lomb extends drop as Wells Fargo downgrades on enVista recall
Bausch + Lomb (NYSE:BLCO) stock falls as the company's voluntary recall of enVista lenses leads to a downgrade at Wells Fargo ...
Bausch + Lomb (NYSE:BLCO) Reaches New 52-Week Low on Analyst Downgrade
Bausch + Lomb Co. (NYSE:BLCO – Get Free Report)’s stock price reached a new 52-week low during trading on Thursday after ...
Bausch & Lomb: Top 10 Undervalued Healthcare Sector Stocks on TSX (BLCO)
Detailed price information for Bausch Lomb Corporation (BLCO-T) from The Globe and Mail including charting and trades.
Seeking Alpha9d
Bausch + Lomb extends drop as Wells Fargo downgrades on enVista recall
Bausch + Lomb (NYSE:BLCO) continued to trade lower on Friday as Wells Fargo downgraded the Canadian eyecare firm in reaction to a voluntary recall of several brands of its enVista line of ...